Literature DB >> 28057432

Pattern of cognitive impairment in patients with Parkinson's disease and psychosis: A critical review.

Abhishek Lenka1, Shantala Hegde2, Shyam Sundar Arumugham3, Pramod Kumar Pal4.   

Abstract

Psychosis is one of the debilitating non-motor symptoms (NMS) of Parkinson's disease (PD). Cognitive impairment is considered to be a risk factor for emergence of psychosis in PD. Early detection of relevant cognitive impairment may serve as a predictor for development of psychosis, with implications for prevention and early intervention. However, the exact pattern of cognitive impairment associated with psychosis is not clear. In this article, we aim to critically review the literature on case-control studies in PD patients with and without psychosis in order to understand the pattern of cognitive impairment in those with psychosis. Majority of studies conducted till date have focused on executive and visuospatial functions. Despite some inconsistencies, most of the studies found significant impairment in these domains in PD patients with psychosis compared to those without psychosis. Studies assessing for other cognitive functions such as attention, language and memory in PD patients have also found worse performance in those with psychosis. Although there is enough evidence to suggest that PD patients with psychosis have poor cognitive functioning, it is unclear if these deficits are generalized or specific. The available evidence, which is primarily in the form of cross-sectional studies assessing for specific cognitive deficits, is not adequate to indicate a clear demarcating pattern of cognitive deficits, which differentiates PD patients with and without psychosis. Longitudinal studies with extensive cognitive assessment are warranted.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Delusions; Parkinson's disease; Psychosis; Visual hallucinations

Mesh:

Year:  2016        PMID: 28057432     DOI: 10.1016/j.parkreldis.2016.12.025

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

1.  Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.

Authors:  Jared T Hinkle; Kate Perepezko; Catherine C Bakker; Ted M Dawson; Vanessa Johnson; Zoltan Mari; Cherie L Marvel; Kelly A Mills; Alexander Pantelyat; Olga Pletnikova; Liana S Rosenthal; Melissa D Shepard; Daniel A Stevens; Juan C Troncoso; Jiangxia Wang; Gregory M Pontone
Journal:  Int J Geriatr Psychiatry       Date:  2017-05-16       Impact factor: 3.485

2.  Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients.

Authors:  Cheng-Jie Mao; Ya-Ping Yang; Ju-Ping Chen; Fen Wang; Jing Chen; Jin-Ru Zhang; Hui-Jun Zhang; Sheng Zhuang; Yi-Tong Xiong; Chen-Chen Gu; Wen Yuan; Juan-Ying Huang; Alexander Fay; Chong-Ke Zhong; Chun-Feng Liu
Journal:  Parkinsonism Relat Disord       Date:  2017-12-21       Impact factor: 4.891

Review 3.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

Review 4.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

5.  Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Venkateswara Reddy; Y C Janardhana Reddy; Ravi Yadav; Pramod Kumar Pal
Journal:  J Neural Transm (Vienna)       Date:  2018-06-01       Impact factor: 3.850

6.  Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Ravi Yadav; Pramod Kumar Pal
Journal:  Neurology       Date:  2020-04-21       Impact factor: 11.800

7.  Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study.

Authors:  M Dauwan; J I Hoff; E M Vriens; A Hillebrand; C J Stam; I E Sommer
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

Review 8.  Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Authors:  Raquel N Taddei; Seyda Cankaya; Sandeep Dhaliwal; K Ray Chaudhuri
Journal:  Parkinsons Dis       Date:  2017-09-12

9.  Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Authors:  Alberto J Espay; Michael T Guskey; James C Norton; Bruce Coate; Joaquin A Vizcarra; Clive Ballard; Stewart A Factor; Joseph H Friedman; Anthony E Lang; Niccole J Larsen; Candace Andersson; Doral Fredericks; Daniel Weintraub
Journal:  Mov Disord       Date:  2018-11-02       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.